Literature DB >> 20723541

Transduction of the inner mouse retina using AAVrh8 and AAVrh10 via intravitreal injection.

Thomas J Giove1, Miguel Sena-Esteves, William D Eldred.   

Abstract

Adeno-associated virus (AAV) is a proven, safe and effective vector for gene delivery in the retina. There are over 100 serotypes of AAV, and AAV2 through AAV9 have been evaluated in the retina. Each AAV serotype has different cell tropism and transduction efficiency. Intravitreal injections of AAV into the eye tend to transduce cells in the ganglion cell layer (GCL), while subretinal injections tend to transduce retinal pigment epithelium and photoreceptors. Efficient transduction of the inner retina beyond the GCL is not well established with the current methodologies and serotypes used to date. In this study, we compared the cellular tropism of AAVrh8 and AAVrh10 vectors encoding enhanced green fluorescent protein (EGFP) using intravitreal injections. We found that AAVrh8 largely transduced cells in the GCL and also amacrine cells in the inner nuclear layer (INL), as well as Müller and horizontal cells. Inner retinal transduction with AAVrh10 was similar to AAVrh8, but AAVrh10 appeared to also transduce bipolar cells. The transduction efficiency as measured by the intensity of EGFP signal was 3.5 fold higher in horizontal cells transduced with AAVrh10 than AAVrh8. Glial fibrillary accessory protein (GFAP) levels were increased in Müller cells in transduced areas for both serotypes. The results of this study suggest that AAVrh8 and AAVrh10 may be excellent vector candidates to deliver genetic material to the INL, particularly for amacrine and horizontal cells, however they may also cause cellular stress as shown by increased glial GFAP expression.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20723541      PMCID: PMC2962726          DOI: 10.1016/j.exer.2010.08.011

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  41 in total

1.  Adeno-associated viruses undergo substantial evolution in primates during natural infections.

Authors:  Guangping Gao; Mauricio R Alvira; Suryanarayan Somanathan; You Lu; Luk H Vandenberghe; John J Rux; Roberto Calcedo; Julio Sanmiguel; Zahra Abbas; James M Wilson
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-25       Impact factor: 11.205

Review 2.  Gene delivery to the eye using adeno-associated viral vectors.

Authors:  Keith R G Martin; Ronald L Klein; Harry A Quigley
Journal:  Methods       Date:  2002-10       Impact factor: 3.608

Review 3.  Intracellular trafficking of adeno-associated viral vectors.

Authors:  W Ding; L Zhang; Z Yan; J F Engelhardt
Journal:  Gene Ther       Date:  2005-06       Impact factor: 5.250

4.  Sustained correction of disease in naive and AAV2-pretreated hemophilia B dogs: AAV2/8-mediated, liver-directed gene therapy.

Authors:  Lili Wang; Roberto Calcedo; Timothy C Nichols; Dwight A Bellinger; Aaron Dillow; Inder M Verma; James M Wilson
Journal:  Blood       Date:  2005-01-06       Impact factor: 22.113

5.  Involvement of adenosine in retinal ischemia. Studies on the rat.

Authors:  A K Larsen; N N Osborne
Journal:  Invest Ophthalmol Vis Sci       Date:  1996-12       Impact factor: 4.799

6.  Morphological types of horizontal cell in rodent retinae: a comparison of rat, mouse, gerbil, and guinea pig.

Authors:  L Peichl; J González-Soriano
Journal:  Vis Neurosci       Date:  1994 May-Jun       Impact factor: 3.241

7.  Virus-mediated transduction of murine retina with adeno-associated virus: effects of viral capsid and genome size.

Authors:  Grace S Yang; Michael Schmidt; Ziying Yan; Jonathan D Lindbloom; Thomas C Harding; Brian A Donahue; John F Engelhardt; Robert Kotin; Beverly L Davidson
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

8.  Development and optimization of a real-time quantitative PCR-based method for the titration of AAV-2 vector stocks.

Authors:  Marlon R Veldwijk; Julian Topaly; Stephanie Laufs; Ulrich R Hengge; Frederik Wenz; W Jens Zeller; Stefan Fruehauf
Journal:  Mol Ther       Date:  2002-08       Impact factor: 11.454

9.  Nonhuman primate models for diabetic ocular neovascularization using AAV2-mediated overexpression of vascular endothelial growth factor.

Authors:  Corinna Lebherz; Albert M Maguire; Alberto Auricchio; Waixing Tang; Tomas S Aleman; Zhangyong Wei; Rebecca Grant; Artur V Cideciyan; Samuel G Jacobson; James M Wilson; Jean Bennett
Journal:  Diabetes       Date:  2005-04       Impact factor: 9.461

Review 10.  Molecular profile of reactive astrocytes--implications for their role in neurologic disease.

Authors:  M Eddleston; L Mucke
Journal:  Neuroscience       Date:  1993-05       Impact factor: 3.590

View more
  15 in total

1.  Structure comparison of the chimeric AAV2.7m8 vector with parental AAV2.

Authors:  Antonette Bennett; Annahita Keravala; Victoria Makal; Justin Kurian; Brahim Belbellaa; Rangoli Aeran; Yu-Shan Tseng; Duncan Sousa; John Spear; Mehdi Gasmi; Mavis Agbandje-McKenna
Journal:  J Struct Biol       Date:  2019-12-16       Impact factor: 2.867

2.  Synthetic Adeno-Associated Viral Vector Efficiently Targets Mouse and Nonhuman Primate Retina In Vivo.

Authors:  Livia S Carvalho; Ru Xiao; Sarah J Wassmer; Aliete Langsdorf; Eric Zinn; Simon Pacouret; Samiksha Shah; Jason I Comander; Leo A Kim; Laurence Lim; Luk H Vandenberghe
Journal:  Hum Gene Ther       Date:  2018-03-20       Impact factor: 5.695

3.  Persistent suppression of ocular neovascularization with intravitreal administration of AAVrh.10 coding for bevacizumab.

Authors:  Yanxiong Mao; Szilard Kiss; Julie L Boyer; Neil R Hackett; Jianping Qiu; Andrew Carbone; Jason G Mezey; Stephen M Kaminsky; Donald J D'Amico; Ronald G Crystal
Journal:  Hum Gene Ther       Date:  2011-10-27       Impact factor: 5.695

4.  Structure of neurotropic adeno-associated virus AAVrh.8.

Authors:  Sujata Halder; Kim Van Vliet; J Kennon Smith; Thao Thi Phuong Duong; Robert McKenna; James M Wilson; Mavis Agbandje-McKenna
Journal:  J Struct Biol       Date:  2015-08-31       Impact factor: 2.867

5.  Heparan Sulfate Binding Promotes Accumulation of Intravitreally Delivered Adeno-associated Viral Vectors at the Retina for Enhanced Transduction but Weakly Influences Tropism.

Authors:  Kenton T Woodard; Katharine J Liang; William C Bennett; R Jude Samulski
Journal:  J Virol       Date:  2016-10-14       Impact factor: 6.549

6.  Efficient gene delivery to photoreceptors using AAV2/rh10 and rescue of the Rho(-/-) mouse.

Authors:  Arpad Palfi; Naomi Chadderton; Mary O'Reilly; Kerstin Nagel-Wolfrum; Uwe Wolfrum; Jean Bennett; Peter Humphries; Paul Kenna; Sophia Millington-Ward; Jane Farrar
Journal:  Mol Ther Methods Clin Dev       Date:  2015-05-06       Impact factor: 6.698

7.  The neostriatum: two entities, one structure?

Authors:  Violeta G Lopez-Huerta; Yoko Nakano; Johannes Bausenwein; Omar Jaidar; Michael Lazarus; Yoan Cherassse; Marianela Garcia-Munoz; Gordon Arbuthnott
Journal:  Brain Struct Funct       Date:  2015-02-05       Impact factor: 3.270

8.  In vivo imaging of adeno-associated viral vector labelled retinal ganglion cells.

Authors:  Corey A Smith; Balwantray C Chauhan
Journal:  Sci Rep       Date:  2018-01-24       Impact factor: 4.379

9.  Tropisms of AAV for subretinal delivery to the neonatal mouse retina and its application for in vivo rescue of developmental photoreceptor disorders.

Authors:  Satoshi Watanabe; Rikako Sanuki; Shinji Ueno; Toshiyuki Koyasu; Toshiaki Hasegawa; Takahisa Furukawa
Journal:  PLoS One       Date:  2013-01-15       Impact factor: 3.240

10.  Novel AAV44.9-Based Vectors Display Exceptional Characteristics for Retinal Gene Therapy.

Authors:  Sanford L Boye; Shreyasi Choudhury; Sean Crosson; Giovanni Di Pasquale; Sandra Afione; Russell Mellen; Victoria Makal; Kaitlyn R Calabro; Diego Fajardo; James Peterson; Hangning Zhang; Matthew T Leahy; Colin K Jennings; John A Chiorini; Ryan F Boyd; Shannon E Boye
Journal:  Mol Ther       Date:  2020-04-11       Impact factor: 12.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.